He has been serving as Director of the McGill Division of Radiation Oncology at the MUHC since 2011. Dr. Abdulkarim received his PhD in radiation biology from Paris XI University in 2002. As a clinician-scientist over the last 13 years, Dr. Abdulkarim has developed extensive expertise in the field of translational research in oncology while leading clinical trials for the identification of blood-based biomarkers for radiation-induced toxicities in breast cancer and response to treatment in high-grade glioma. He is internationally recognized for seminal work in the field of breast cancer subtypes and risk of locoregional recurrence. Dr. Abdulkarim has received a number of awards and honours during his career.